| Chemical and physical data | |
|---|---|
| Formula | C32H32ClN3O3 |
| Molar mass | 542.08 g·mol−1 |
| 3D model (JSmol) |
|
| |
CL 110,393 is an opioid drug derived from thebaine, closely related to the family of drugs known as the Bentley compounds which includes better known examples such as buprenorphine, etorphine and diprenorphine. Unlike most other related compounds, CL 110,393 acts as a highly selective κ-opioid receptor agonist with negligible activity at the μ-opioid receptor. It produces hallucinogenic effects with high potency and a long duration of action, as well as side effects such as dysphoria, tinnitus, slurred speech, ataxia, perspiration and tingling of the skin, and was investigated as a non-lethal incapacitating agent.[1][2][3]
See also
References
- ^ Martin WR (1967). "Opioid Antagonists". Pharmacological Reviews. 19 (4): 463–521. doi:10.1016/S0031-6997(25)07161-3.
- ^ Eddy NB, Martin WR (1970). "Drug Dependence of Specific Opiate Antagonist Type". Pharmacopsychiatry. 3 (2): 73–82. doi:10.1055/s-0028-1094264.
- ^ Angrist B, Gershon S (May 1973). "Behavioral profile of a potent new psychotoxic compound". Psychopharmacologia. 30 (2): 109–116. doi:10.1007/BF00421425. PMID 4711368.